TB500 + BPC157 Re-Usable Metal Pen Kit
BPC-157 + TB-500
Research Peptide Blend for Equine & Small Animal Research
Peptide Names: BPC-157 + TB-500Research Category: Tissue repair, musculoskeletal recovery, angiogenesis, inflammatory-response researchCAS Numbers:BPC-157: 137525-51-0TB-500 / Thymosin β4 fragment-related research: 75591-33-4
Product Overview
BPC-157 + TB-500 is a dual-peptide research blend developed for use in equine and small-animal research settings, with particular interest in models involving soft-tissue repair, tendon and ligament recovery, wound-healing pathways, angiogenesis, collagen formation, and inflammatory-response signalling.
This blend is especially relevant to horses, where musculoskeletal strain, tendon stress, ligament injury, and soft-tissue recovery are major areas of veterinary and performance-animal research. It may also be of interest in small-animal research models involving connective tissue, skin, wound repair, and inflammatory modulation.
The scientific interest in this combination comes from the complementary research profiles of each peptide:
BPC-157 has been studied mainly in preclinical animal models for its role in soft-tissue healing, tendon and ligament repair, muscle injury recovery, angiogenesis, collagen organisation, nitric-oxide pathway modulation, and gastrointestinal tissue protection. Reviews note that much of the evidence remains preclinical, with limited approved veterinary or clinical use data.
TB-500 is commonly associated with research on Thymosin β4, a naturally occurring peptide involved in actin binding, cell migration, angiogenesis, and wound repair. Animal studies and reviews have reported that Thymosin β4 can promote angiogenesis, support dermal wound repair, influence inflammatory-cell migration, and contribute to tissue-repair processes.
Key Research Areas
1. Equine Soft-Tissue & Musculoskeletal Research
Horses are highly prone to tendon, ligament, joint, and muscle strain due to their size, athletic workload, and repetitive mechanical stress. BPC-157 has been investigated in animal models involving tendon, ligament, skeletal muscle, and bone repair, with researchers reporting effects on healing pathways, collagen organisation, and tissue remodelling.
Research relevance:May be studied in relation to equine soft-tissue repair pathways, including tendon, ligament, muscle, and joint-support research.
2. Wound-Healing & Cellular Migration Research
Thymosin β4 has been widely studied for its role in wound-healing biology. Peer-reviewed animal research has shown that it can promote keratinocyte and endothelial-cell migration, support new blood-vessel formation, and accelerate wound closure in experimental wound models.
Research relevance:May be investigated in wound-healing, skin-repair, and tissue-regeneration research models in horses and small animals.
3. Angiogenesis & Blood-Flow Pathway Research
Angiogenesis — the formation of new blood vessels — is a critical part of tissue repair. Thymosin β4 has been shown in animal and cellular models to promote angiogenesis, while BPC-157 research has also reported effects on vascular and nitric-oxide-related pathways.
Research relevance:May be studied where improved vascular response, tissue oxygenation, and repair signalling are areas of interest.
4. Collagen & Structural Integrity Research
Collagen is central to tendon, ligament, skin, and connective-tissue strength. BPC-157 has been reviewed for its effects in animal models of tendon, ligament, muscle, and connective-tissue repair, with proposed mechanisms including fibroblast activity, collagen formation, and tissue remodelling.
Research relevance:May be studied in relation to connective-tissue structure, tendon-fibre organisation, and post-injury tissue remodelling.
5. Inflammatory-Response Research
Both BPC-157 and Thymosin β4 have been investigated for roles in inflammatory-response modulation. Thymosin β4 has been reviewed for effects on wound repair, inflammation-associated cell migration, and tissue protection, while BPC-157 studies have examined nitric-oxide signalling and inflammatory pathways in preclinical models.
Research relevance:May be used in research models studying inflammatory signalling after soft-tissue stress or injury.
Suitable Research Focus
This peptide blend is positioned for research involving:
Equine tendon and ligament-repair pathways
Muscle and soft-tissue recovery models
Wound-healing and skin-repair research
Angiogenesis and vascular-response studies
Collagen synthesis and connective-tissue remodelling
Small-animal tissue-repair and inflammation models
Important Research Disclaimer
This product is supplied for laboratory and research purposes only. It is not intended to diagnose, treat, cure, or prevent any disease or injury in horses, companion animals, livestock, or humans. It is not a registered veterinary medicine and should not be presented as a treatment product.
Use only in accordance with applicable research, laboratory, and regulatory requirements.
References
Chang, C.H. et al. “The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon fibroblast outgrowth, cell survival, and cell migration.” Journal of Applied Physiology, 2011.
Relevant to: BPC-157 tendon-healing, fibroblast migration, and soft-tissue repair research.
Abstract:
Staresinic, M. et al. “Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon.” Journal of Orthopaedic Research, 2003.
Relevant to: BPC-157 tendon-repair research in an animal model.
Abstract:
Gwyer, D. et al. “Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing.” Cell and Tissue Research, 2019.
Relevant to: BPC-157 musculoskeletal, tendon, ligament, and muscle-repair research review.
Abstract:
Philp, D. et al. “Thymosin beta4 promotes angiogenesis, wound healing, and hair follicle development.” Mechanisms of Ageing and Development, 2004.
Relevant to: Thymosin β4/TB-500-related angiogenesis, wound-healing, and tissue-repair research.
Abstract:
Malinda, K.M. et al. “Thymosin β4 accelerates wound healing.” Journal of Investigative Dermatology, 1999.
Relevant to: Thymosin β4 wound-healing, collagen deposition, keratinocyte migration, and angiogenesis research.
Abstract:
Ho, E.N.M. et al. “Doping control analysis of TB-500, a synthetic version of an active region of thymosin β4, in equine plasma.” Drug Testing and Analysis, 2012.
Relevant to: Equine-specific TB-500 / Thymosin β4 detection and regulatory context.
Abstract:
Important Research Disclaimer
This product is supplied for laboratory and research purposes only. It is not intended to diagnose, treat, cure, or prevent any disease, injury, or condition in horses, companion animals, livestock, or humans. It is not a registered veterinary medicine and should not be presented, marketed, or used as a treatment product.
Any references to tendon repair, wound-healing pathways, angiogenesis, collagen formation, inflammatory-response signalling, or musculoskeletal recovery relate strictly to published preclinical, laboratory, or animal-model research and should not be interpreted as veterinary medical claims.
Use only in accordance with applicable research, laboratory, animal-welfare, and regulatory requirements.
